These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 29530846

  • 1. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
    Kimura M, Araoka H, Yamamoto H, Nakamura S, Nagi M, Yamagoe S, Miyazaki Y, Ogura S, Mitsuki T, Yuasa M, Kaji D, Kageyama K, Nishida A, Taya Y, Shimazu H, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A.
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530846
    [Abstract] [Full Text] [Related]

  • 2. Factors Associated with Breakthrough Fungemia Caused by Candida, Trichosporon, or Fusarium Species in Patients with Hematological Disorders.
    Kimura M, Asano-Mori Y, Sakoh T, Abe M, Ueno K, Hoshino Y, Nakamura S, Umeyama T, Yamagoe S, Miyazaki Y, Baba M, Okada C, Ogura S, Mitsuki T, Yamaguchi K, Yuasa M, Kaji D, Kageyama K, Nishida A, Taya Y, Ishiwata K, Takagi S, Yamamoto H, Yamamoto G, Uchida N, Wake A, Taniguchi S, Araoka H.
    Antimicrob Agents Chemother; 2022 Mar 15; 66(3):e0208121. PubMed ID: 35041512
    [Abstract] [Full Text] [Related]

  • 3. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
    Bayramoglu G, Sonmez M, Tosun I, Aydin K, Aydin F.
    Infection; 2008 Feb 15; 36(1):68-70. PubMed ID: 17882360
    [Abstract] [Full Text] [Related]

  • 4. Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital.
    Kimura M, Araoka H, Yamamoto H, Asano-Mori Y, Nakamura S, Yamagoe S, Ohno H, Miyazaki Y, Abe M, Yuasa M, Kaji D, Kageyama K, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Uchida N, Izutsu K, Wake A, Taniguchi S, Yoneyama A.
    Antimicrob Agents Chemother; 2017 Apr 15; 61(4):. PubMed ID: 28115352
    [Abstract] [Full Text] [Related]

  • 5. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov 15; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 6. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M, Bom VL, de Castro PA, Winkelstroter LK, Ramalho LN, Brown NA, Goldman GH.
    Virulence; 2015 Nov 15; 6(5):476-86. PubMed ID: 25751127
    [Abstract] [Full Text] [Related]

  • 7. The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients.
    Kuo SH, Lu PL, Chen YC, Ho MW, Lee CH, Chou CH, Lin SY.
    J Formos Med Assoc; 2021 Sep 15; 120(9):1686-1694. PubMed ID: 33358563
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
    Itoh K, Iwasaki H, Negoro E, Shigemi H, Tokimatsu I, Tsutani H, Yamauchi T.
    Mycopathologia; 2021 Mar 15; 186(1):113-117. PubMed ID: 33389484
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A case of bloodstream co-infection of Saccharomyces cerevisiae and Candida glabrata while using micafungin.
    Furuya K, Ito K, Sugiyama K, Tokuda S, Kanemoto H, Kamei K, Shimada T.
    BMC Infect Dis; 2023 May 16; 23(1):329. PubMed ID: 37193982
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes.
    McCarty TP, Lockhart SR, Moser SA, Whiddon J, Zurko J, Pham CD, Pappas PG.
    J Antimicrob Chemother; 2018 Jun 01; 73(6):1677-1680. PubMed ID: 29506044
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Breakthrough fungemia due to Candida fermentati with fks1p mutation under micafungin treatment in a cord blood transplant recipient.
    Konuma T, Takahashi S, Kiyuna T, Miharu Y, Suzuki M, Shibata H, Kato S, Takahashi S, Tojo A.
    Transpl Infect Dis; 2017 Feb 01; 19(1):. PubMed ID: 27859978
    [Abstract] [Full Text] [Related]

  • 19. Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital.
    Sakagami T, Kawano T, Yamashita K, Yamada E, Fujino N, Kaeriyama M, Fukuda Y, Nomura N, Mitsuyama J, Suematsu H, Watanabe H, Asai N, Koizumi Y, Yamagishi Y, Mikamo H.
    J Infect Chemother; 2019 Jan 01; 25(1):34-40. PubMed ID: 30401513
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.